Clinical Trial

Epidemiology and Biomarker Study in Alzheimer's Disease

Name: Epidemiology and Biomarker Study in Alzheimer's Disease — clinical trial record (NCT07142954)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ANCHOR-AD

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Study AACU determines rates of cognitive worsening in participants within elevated and not elevated plasma P-tau217 cohorts. Participation in AACU will last approximately 7 years.

Trial Details

NCT Number	NCT07142954
Lead Sponsor	Eli Lilly and Company
Conditions	Alzheimer Disease
Enrollment	3,400 participants
Start Date	2025-08-25
Primary Completion	2033-07 (estimated)
Study Completion	2033-07 (estimated)
Updated on ClinicalTrials.gov	2026-07-07